Skip to main content
Eleftherios Mamounas, MD, General Surgery, Orlando, FL, Orlando Regional Medical Center

EleftheriosPMamounasMD

General Surgery Orlando, FL

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Northeast Ohio Medical University

Dr. Mamounas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mamounas' full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Surgery, 1984 - 1989
  • University of Athens
    University of AthensClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2012 - 2023
  • OH State Medical License
    OH State Medical License 1997 - 2014
  • PA State Medical License
    PA State Medical License 1985 - 1998
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Journal Articles

  • 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast Cancer  
    Eleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
  • Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic Era  
    Eleftherios Mamounas, MD, Nature

Lectures

  • NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
    2019 ASCO Annual Meeting - 6/1/2019
  • NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Do Trials Results Conflict for Extended AI in Breast Cancer?
    Do Trials Results Conflict for Extended AI in Breast Cancer?December 8th, 2016
  • 21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG Oncology
    21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
  • Conversations with Oncology Investigators Bridging the Gap Between Research and Patient Care
    Conversations with Oncology Investigators Bridging the Gap Between Research and Patient CareDecember 26th, 2007

Professional Memberships

Hospital Affiliations